THE Therapeutic Goods Administration (TGA) has updated the database of section 19A approvals to import and supply medicines to address product shortages.
The regulator has given the green-light for Ranbaxy UK's sertraline 50 and 100mg film-coated tablets to be supplied until 30 Jun, as a result of shortages across a range of Australian Register of Therapeutica Goods listed brands.
Shortages of Actemra tocilizumab injection preparations has seen specific Roche Germany RoActemra tocilizumab infusion products get s19A approval until 28 Feb.
CLICK HERE for more.
The above article was sent to subscribers in Pharmacy Daily's issue from 25 Jan 22
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 25 Jan 22
